Head and neck cancer. 3. Toxicity of 24-hour infusions of methotrexate (NSC-740) and protection by leucovorin (NSC-3590) in patients with epidermoid carcinomas. [electronic resource]
- Cancer chemotherapy reports Sep 1967
- 305-11 p. digital
Publication Type: Clinical Trial; Journal Article
0069-0112
Adult Aged Carcinoma, Squamous Cell--drug therapy Clinical Trials as Topic Female Head and Neck Neoplasms--drug therapy Humans Leucovorin--therapeutic use Male Methotrexate--adverse effects Middle Aged Mouth Neoplasms--drug therapy